About: Insulin aspart   Sponge Permalink

An Entity of Type : owl:Thing, within Data Space : 134.155.108.49:8890 associated with source dataset(s)

Insulin aspart (brand names Novolog[1] and Novorapid[2]) is a rapid-acting insulin produced by Novo Nordisk. It is generally taken at or shortly after mealtimes and has a typical duration profile of three to four hours. Novorapid is approved for insulin pump use as well as to be taken before meals through a syringe.

AttributesValues
rdfs:label
  • Insulin aspart
rdfs:comment
  • Insulin aspart (brand names Novolog[1] and Novorapid[2]) is a rapid-acting insulin produced by Novo Nordisk. It is generally taken at or shortly after mealtimes and has a typical duration profile of three to four hours. Novorapid is approved for insulin pump use as well as to be taken before meals through a syringe.
sameAs
dcterms:subject
onset
  • 300.0
peaktime
  • 3600.0
dbkwik:diabetes/pr...iPageUsesTemplate
Duration
  • 14400.0
abstract
  • Insulin aspart (brand names Novolog[1] and Novorapid[2]) is a rapid-acting insulin produced by Novo Nordisk. It is generally taken at or shortly after mealtimes and has a typical duration profile of three to four hours. Novorapid is approved for insulin pump use as well as to be taken before meals through a syringe.
Alternative Linked Data Views: ODE     Raw Data in: CXML | CSV | RDF ( N-Triples N3/Turtle JSON XML ) | OData ( Atom JSON ) | Microdata ( JSON HTML) | JSON-LD    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3217, on Linux (x86_64-pc-linux-gnu), Standard Edition
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2012 OpenLink Software